Filing Details

Accession Number:
0001493152-21-029973
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-29 12:46:33
Reporting Period:
2021-11-24
Accepted Time:
2021-11-29 12:46:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1321834 Mymd Pharmaceuticals Inc. MYMD In Vitro & In Vivo Diagnostic Substances (2835) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1524858 Joshua Silverman 855 N. Wolfe Street, Suite 623
Baltimore MD 21205
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-24 6,734 $6.30 80,509 No 4 P Direct
Common Stock Acquisiton 2021-11-24 3,266 $7.09 83,775 No 4 P Direct
Common Stock Acquisiton 2021-11-26 5,000 $7.55 88,775 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.97 to $6.96, inclusive. The reporting person undertakes to provide to MyMD Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.97 to $7.17, inclusive.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.07 to $7.70, inclusive.